STIM2 and breast carcinoma: Another study, based on the microarray data analyses of 295 breast cancer patients, also showed that transcriptionally-defined basal-like tumors, which have a poor prognosis and lack of effective therapies [74], are characterized by high STIM1 and low STIM2 mRNA expressions [67].